Literature DB >> 4949489

Cellular reaction in the footpad and draining lymph nodes of mice induced by mycobacterial fractions and BCG bacilli.

A Bekierkunst, I S Levij, E Yarkoni, E Vilkas, E Lederer.   

Abstract

Ten micrograms of trehalose-6, 6'-dimycolate (cord factor), injected into the footpad of mice, induced histological changes similar to those following injection of living BCG bacilli. Both materials induced in the draining lymph nodes the formation of granulomas composed of epitheloid cells, macrophages, and small numbers of lymphocytes. Apart from the granulomatous inflammatory process, marked hyperplasia of the lymphoid tissue in the paracortical zone of the nodes and accumulations of macrophages were evident. In some cases, the macrophages were very numerous and replaced part of the lymphoid tissue. Compared to cord factor, wax D showed weak granulomagenic activity. Only slight and transient inflammation was found in the footpads as well as transient slight lymphoid hyperplasia. Wax D also induced small accumulations of macrophages. Complete Freund's adjuvant induced, under the same experimental conditions, large accumulations of macrophages in the draining lymphnode and lymphoid hyperplasia in the paracortical zone. No cellular reaction was seen in the liver, spleen, and lungs after injection of cord factor and BCG into the footpads of the animals. The results and implications are discussed.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4949489      PMCID: PMC416296          DOI: 10.1128/iai.4.3.245-255.1971

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  AN ACUTE PULMONARY GRANULOMATOUS RESPONSE IN MICE PRODUCED BY MYCOBACTERIAL CELLS AND ITS RELATION TO INCREASED RESISTANCE AND INCREASED SUSCEPTIBILITY TO EXPERIMENTAL TUBERCULOUS INFECTION.

Authors:  G P YOUMANS; A S YOUMANS
Journal:  J Infect Dis       Date:  1964-04       Impact factor: 5.226

2.  Studies on the mechanism of non-specific resistance to Brucella induced in mice by vaccination with BCG.

Authors:  D SULITZEANU; A BEKIERKUNST; L GROTO; J LOEBEL
Journal:  Immunology       Date:  1962-01       Impact factor: 7.397

3.  [Cross resistance in experimental tuberculosis and brucellosis in mice].

Authors:  D BEKIERKUNST; D SULITZEANU; I HALPERN
Journal:  Harefuah       Date:  1959-05-15

4.  Studies of resistance to experimental tuberculosis in mice vaccinated with living attenuated tubercle bacilli and challenged with virulent organisms.

Authors:  C L LARSON; W C WICHT
Journal:  Am Rev Respir Dis       Date:  1962-06

5.  [Non specific active immunotherapy by B.C.G. in virus induced leukemia in E male G2 mice in isogenic receiptients].

Authors:  J L Amiel
Journal:  Rev Fr Etud Clin Biol       Date:  1967-11

6.  Recent studies on acquired immunity in tuberculosis.

Authors:  G P Youmans; A S Youmans
Journal:  Curr Top Microbiol Immunol       Date:  1969       Impact factor: 4.291

7.  Histological changes evoked in mice by Freund's complete adjuvant.

Authors:  R L Carter; D G Jamison; R L Vollum
Journal:  J Pathol       Date:  1969-03       Impact factor: 7.996

8.  Effectiveness of cell walls of Mycobacterium bovis strain BCG administered by various routes and in different adjuvants in protecting mice against airborne infection with Mycobacterium tuberculosis strain H37Rv.

Authors:  R L Anacker; W R Barclay; W Brehmer; G Goode; R H List; E Ribi; D F Tarmina
Journal:  Am Rev Respir Dis       Date:  1969-02

9.  Studies on antibody production. IV. The role of a wax fraction of Mycobacterium tuberculosis in adjuvant emulsions on the production of antibody to egg albumin.

Authors:  R G WHITE; A H COONS; J M CONNOLLY
Journal:  J Exp Med       Date:  1955-07-01       Impact factor: 14.307

10.  Multiplication and survival of tubercle bacilli in the organs of mice.

Authors:  C H PIERCE; R J DUBOS; W B SCHAEFER
Journal:  J Exp Med       Date:  1953-02-01       Impact factor: 14.307

View more
  19 in total

1.  Stimulation of lymphocyte proliferation by killed mycobacteria and other bacterial species.

Authors:  A Bekierkunst
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

2.  Granuloma formation in lungs of mice after intravenous administration of emulsified trehalose-6,6'-dimycolate (cord factor): reaction intensity depends on size distribution of the oil droplets.

Authors:  E Yarkoni; H J Rapp
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

Review 3.  Mycobacterial lipids: selected topics.

Authors:  M B Goren
Journal:  Bacteriol Rev       Date:  1972-03

4.  Isolation and properties of a macromolecular, water-soluble, immuno-adjuvant fraction from the cell wall of Mycobacterium smegmatis.

Authors:  A Adam; R Ciorbaru; J F Petit; E Lederer
Journal:  Proc Natl Acad Sci U S A       Date:  1972-04       Impact factor: 11.205

5.  Failure of trehalose-6,6'-dimycolate (P3 or cord factor) to enhance endotoxin lethality in mice.

Authors:  E Yarkoni; M S Meltzer; H J Rapp
Journal:  Infect Immun       Date:  1976-12       Impact factor: 3.441

6.  Immune response to sheep red blood cells in mice pretreated with mycobacterial fractions.

Authors:  A Bekierkunst; E Yarkoni; I Flechner; S Morecki; E Vilkas; E Lederer
Journal:  Infect Immun       Date:  1971-09       Impact factor: 3.441

7.  Granulomagenic activity of serologically active glycolipids from Mycobacterium bovis BCG.

Authors:  Z Reggiardo; A K Shamsuddin
Journal:  Infect Immun       Date:  1976-12       Impact factor: 3.441

8.  Granulomatous hypersensitivity to trehalose-6,6'-dimycolate (cord factor) in mice infected with BCG.

Authors:  A Bekierkunst; E Yarkoni
Journal:  Infect Immun       Date:  1973-04       Impact factor: 3.441

9.  Induction of cell-mediated immunity to Mycobacterium leprae in guinea pigs.

Authors:  V Mehra; B R Bloom
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

10.  Nonspecific resistance against infection with Salmonella typhi and Salmonella typhimurium induced in mice by cord factor (trehalose-6,6'-dimycolate) and its analogues.

Authors:  E Yarkoni; A Bekierkunst
Journal:  Infect Immun       Date:  1976-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.